Agile Therapeutics Long Term Debt 2013-2023 | AGRX
Agile Therapeutics long term debt from 2013 to 2023. Long term debt can be defined as the sum of all long term debt fields.
Agile Therapeutics Annual Long Term Debt
(Millions of US $) |
| 2023 |
$ |
| 2022 |
$ |
| 2021 |
$ |
| 2020 |
$16 |
| 2019 |
$ |
| 2018 |
$ |
| 2017 |
$ |
| 2016 |
$11 |
| 2015 |
$13 |
| 2014 |
$10 |
| 2013 |
$10 |
| 2012 |
$15 |
Agile Therapeutics Quarterly Long Term Debt
(Millions of US $) |
| 2023-12-31 |
|
| 2023-09-30 |
|
| 2023-06-30 |
|
| 2023-03-31 |
|
| 2022-12-31 |
|
| 2022-09-30 |
|
| 2022-06-30 |
|
| 2022-03-31 |
|
| 2021-12-31 |
|
| 2021-09-30 |
$16 |
| 2021-06-30 |
$16 |
| 2021-03-31 |
$16 |
| 2020-12-31 |
$16 |
| 2020-09-30 |
$16 |
| 2020-06-30 |
$16 |
| 2020-03-31 |
$15 |
| 2019-12-31 |
|
| 2019-09-30 |
|
| 2019-06-30 |
|
| 2019-03-31 |
|
| 2018-12-31 |
|
| 2018-09-30 |
|
| 2018-06-30 |
|
| 2018-03-31 |
|
| 2017-12-31 |
|
| 2017-09-30 |
$6 |
| 2017-06-30 |
$8 |
| 2017-03-31 |
$9 |
| 2016-12-31 |
$11 |
| 2016-09-30 |
$12 |
| 2016-06-30 |
$10 |
| 2016-03-31 |
$11 |
| 2015-12-31 |
$13 |
| 2015-09-30 |
$15 |
| 2015-06-30 |
$15 |
| 2015-03-31 |
$15 |
| 2014-12-31 |
$10 |
| 2014-09-30 |
$11 |
| 2014-06-30 |
$13 |
| 2014-03-31 |
|
| 2013-12-31 |
|
| 2013-09-30 |
|
| 2013-06-30 |
|
| 2012-12-31 |
$15 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.003B |
$0.020B |
|
Agile Therapeutics, Inc. is a women's health specialty pharmaceutical company. It is focused on the development and commercialization of new prescription contraceptive products. The Company's lead product candidate is Twirla (TM), also known as AG200-15, a once-weekly prescription contraceptive patch currently in Phase 3 clinical development. Agile Therapeutics, Inc. is headquartered in Princeton, New Jersey.
|
